BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27406051)

  • 1. Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.
    Rakha EA; Bennett RL; Coleman D; Pinder SE; Ellis IO;
    J Clin Pathol; 2017 Jan; 70(1):51-57. PubMed ID: 27406051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a national external quality assessment scheme for breast pathology in the UK.
    Ellis IO; Coleman D; Wells C; Kodikara S; Paish EM; Moss S; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly CE; Dallimore NS; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Parham D; Patnick J; Pinder SE; Quinn CM; Robertson AJ; Shrimankar J; Walker RA; Winder R
    J Clin Pathol; 2006 Feb; 59(2):138-45. PubMed ID: 16443727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.
    Sloane JP; Ellman R; Anderson TJ; Brown CL; Coyne J; Dallimore NS; Davies JD; Eakins D; Ellis IO; Elston CW
    Eur J Cancer; 1994; 30A(10):1414-9. PubMed ID: 7833094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.
    Rakha EA; Ahmed MA; Aleskandarany MA; Hodi Z; Lee AH; Pinder SE; Ellis IO
    Histopathology; 2017 Mar; 70(4):632-642. PubMed ID: 28028831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal.
    Parham DM; Coleman D; Kodikara S; Moss S; Ellis IO; Al-Sam S; Anderson N; Bobrow L; Buley I; Connolly CE; Dallimore NS; Hales S; Hanby A; Humphreys S; Knox F; Lowe J; Macartney J; Nash R; Patnick J; Pinder SE; Quinn CM; Robertson AJ; Shrimankar J; Walker RA; Wells C; Winder R; Patel N
    J Clin Pathol; 2006 Feb; 59(2):130-7. PubMed ID: 16443726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary carcinoma of the breast: diagnostic agreement and management implications.
    Rakha EA; Ahmed MA; Ellis IO
    Histopathology; 2016 Nov; 69(5):862-870. PubMed ID: 27270947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic concordance of reporting lymphovascular invasion in breast cancer.
    Rakha EA; Abbas A; Pinto Ahumada P; ElSayed ME; Colman D; Pinder SE; Ellis IO
    J Clin Pathol; 2018 Sep; 71(9):802-805. PubMed ID: 29599396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance in breast cancer screening cytology: a review of the literature and a report on the U.K. national cytology scheme.
    Wells CA
    Eur J Cancer; 1995; 31A(2):273-80. PubMed ID: 7718337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
    Pinder SE; Ellis IO
    Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Eusebi V; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
    Virchows Arch; 1999 Jan; 434(1):3-10. PubMed ID: 10071228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
    Masood S
    Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic concordance of phyllodes tumour of the breast.
    Rakha E; Mihai R; Abbas A; Bennett R; Campora M; Morena P; Toss M; Ellis I
    Histopathology; 2021 Oct; 79(4):607-618. PubMed ID: 33966296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue.
    Apple SK
    Breast J; 2006; 12(2):145-9. PubMed ID: 16509839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.
    MacGrogan G; Arnould L; de Mascarel I; Vincent-Salomon A; Penault-Llorca F; Lacroix-Triki M; Bibeau F; Baranzelli MC; Fridman V; Antoine M; Bécette V; Brouste V; Jacquemier J; Mathoulin-Pélissier S;
    Histopathology; 2008 May; 52(6):689-97. PubMed ID: 18397281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External quality assessment in gynaecological cytology: The Trent Region experience. The Trent Regional Gynaecological Pathology Quality Assurance Group for the National Health Service Cervical Screening Programme.
    Slater DN; Hewer EM; Melling SE; Rice S
    Cytopathology; 2002 Aug; 13(4):206-19. PubMed ID: 12269893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a technical external quality assurance scheme in non-gynaecological cytology in UK.
    Cross PA; Hodgson C; Crossley J; Crossley B
    Cytopathology; 2015 Apr; 26(2):71-4. PubMed ID: 25800804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.